Skip to content
TrialScanner

NCT00473824

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Phase 2TerminatedADMALead

Registry record

Lead sponsor
ADMA Biologics, Inc.
Conditions
Sequelae of Viral Hepatitis; Transplantation Infection; Evidence of Liver Transplantation
Primary completion
Feb 2009Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00473824 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00473824: Randomized Phase II Study of... | TrialScanner